Rituximab for Graft-Versus-Host-Disease-Prophylaxis after Allogeneic Stem Cell Transplantation Given as Treatment of High Risk Relapse of Aggressive Lymphoma: Results of a Randomized Phase II Study

ISSN
0006-4971
Date Issued
2008
Author(s)
Glass, Bertram
Dreger, Peter
Schubert, Joerg
Nickelsen, Maike
Schmitz, Norbert